Radcliffe Capital Management’s Aspire Biopharma Holdings, Inc. Common Stock ASBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-102,184
| Closed | -$1.11M | – | 100 |
|
|
2023
Q4 | $1.11M | Buy |
102,184
+490
| +0.5% | +$5.34K | 0.15% | 105 |
|
|
2023
Q3 | $1.1M | Sell |
101,694
-48,306
| -32% | -$523K | 0.14% | 157 |
|
|
2023
Q2 | $1.59M | Sell |
150,000
-501,302
| -77% | -$5.3M | 0.14% | 197 |
|
|
2023
Q1 | $6.84M | Buy |
651,302
+11,361
| +2% | +$119K | 0.43% | 58 |
|
|
2022
Q4 | $6.59M | Buy |
639,941
+339,853
| +113% | +$3.5M | 0.21% | 127 |
|
|
2022
Q3 | $3.04M | Buy |
300,088
+88
| +0% | +$892 | 0.07% | 447 |
|
|
2022
Q2 | $2.99M | Buy |
+300,000
| New | +$2.99M | 0.07% | 482 |
|